Ocugen, Inc.
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
OCGN | NDAQ
Overview
Corporate Details
- ISIN(s):
- US43358V1098 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 11 GREAT VALLEY PARKWAY, 19355 MALVERN
- Website:
- https://ocugen.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Ocugen, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing novel gene therapies, cell therapies, and vaccines. The company is a pioneer in developing treatments for blindness diseases, leveraging its breakthrough modifier gene therapy platform to address significant unmet medical needs in inherited retinal diseases. Ocugen's development pipeline also extends to vaccines and other biologics aimed at improving public health. The company operates with a patient-centric mission to deliver innovative therapeutic solutions for conditions with limited or no available treatment options.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Ocugen, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ocugen, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ocugen, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
